Exopolysaccharides enriched in rare suggars: bacterial sources, production and applications by Roca, Christophe et al.
MINI REVIEW















Lab. 407, Research Unit on Applied
Molecular Biosciences, Rede de
Química e Tecnologia, Departamento
de Química, Faculdade de Ciências e





This article was submitted
to Microbiotechnology, Ecotoxicology
and Bioremediation, a section
of the journal Frontiers in Microbiology
Received: 04 February 2015
Paper pending published:
28 February 2015
Accepted: 23 March 2015
Published: 10 April 2015
Citation:
Roca C, Alves VD, Freitas F
and Reis MAM (2015)





Exopolysaccharides enriched in rare
sugars: bacterial sources,
production, and applications
Christophe Roca 1, Vitor D. Alves 2, Filomena Freitas 1* and Maria A. M. Reis 1
1 Research Unit on Applied Molecular Biosciences, Rede de Química e Tecnologia, Departamento de Química, Faculdade de
Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal, 2 Linking Landscape, Environment, Agriculture and
Food, Instituto Superior de Agronomia, Universidade de Lisboa, Lisboa, Portugal
Microbial extracellular polysaccharides (EPS), produced by a wide range of bacteria, are
high molecular weight biopolymers, presenting an extreme diversity in terms of chemical
structure and composition. They may be used in many applications, depending on their
chemical and physical properties. A rather unexplored aspect is the presence of rare
sugars in the composition of some EPS. Rare sugars, such as rhamnose or fucose,
may provide EPS with additional biological properties compared to those composed of
more common sugar monomers. This review gives a brief overview of these specific EPS
and their producing bacteria. Cultivation conditions are summarized, demonstrating their
impact on the EPS composition, together with downstream processing. Finally, their use
in different areas, including cosmetics, food products, pharmaceuticals, and biomedical
applications, are discussed.
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Introduction
Bacterial extracellular polysaccharides (EPS) presenting a wide range of physicochemical properties
have emerged as promising polymers for many commercial applications in different industrial
sectors like food, pharmaceuticals, cosmetics, oil drilling, and paper manufacturing (Kumar and
Mody, 2009; Freitas et al., 2011a). Despite this potential, bacterial EPS currently represent a very
small fraction of the global polymer market, mostly because of their production costs. However,
in some cases, they might address very specific niche markets, where the production cost does not
become a limiting step for their commercialization (Freitas et al., 2011a).
Rare sugars are monosaccharides that are not commonly found in nature, where -glucose,
-galactose, -fructose, -xylose, -ribose, and -arabinose are more abundant. Rare sugars such as
-fucose, -rhamnose, or uronic acids present many interesting properties, making them attractive
for various fields of applications, such as anti-inflammatory substances, antioxidant, or as building
blocks to synthesize the nucleoside analogs which are used as antiviral agents, and justifying the
effort to produce them synthetically (Kumar et al., 2007). Today, some of them might be produced
biochemically by the use of specialized enzymes belonging usually to the classes of keto–aldol
isomerases, epimerases, and oxidoreductases using glucose as main precursor (Granström et al.,
2004; Beerens et al., 2012). Their scarceness makes them highly valuable and, consequently, bacterial
EPS containing rare sugars represent an interesting source for their isolation and production.
Although polysaccharides containing rare sugars are also found in plants, seaweeds, and animals,
microbial production of such polymers is advantageous for several reasons, namely, production is
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TABLE 1 | Production and composition details of some bacterial polysaccharides rich in rare sugars.







Sucrose 19.9–22.6 6.6–9.0 Zhang et al. (2015)
Glucose 12.4 7.4 Giavasis et al. (2003)
Whey 1.6–3.1 0.6–1.2 Dlamini and Peiris (1997)
Acetyl and glyceryl groups Soluble starch 37.5–43.6 14.5–18.8 Bajaj et al. (2006)
Molasses 13.8 n.a. Banik et al. (2007)
Welan Alcaligenes sp. Rhamnose, glucose, and
glucuronic acid
Glucose 25.0–26.3 8.3–8.8 Li et al. (2011)





Glucose 0.7 0.06 van den Bulk et al. (1991)
Acetyl, pyruvyl, and succinyl
groups
FucoPol Enterobacter A47 Fucose, glucose, galactose,
and glucuronic acid
Glycerol 7.5–8.0 2.0–2.5 Torres et al. (2012)
Glucose 13.4 3.4 Freitas et al. (2014)
Xylose 5.4 1.4 Freitas et al. (2014)




Streptococcus sp. Glucuronic acid and
acetylglucosamine
Glucose 0.4–6.9 0.8–1.5 Huang et al. (2008)
FIGURE 1 | Schematic diagram of the biosynthetic pathways in
Gram-negative bacteria involved in the intracellular synthesis of
nucleoside diphosphate sugars that are precursors of some rare
sugar monomers (Fuc, fucose; Glc, glucose; GlcA, glucuronic acid;
Man, mannose; Rha, rhamnose; Fru, fructose; GDP, guanosine
diphosphate; TDP, tyrosine diphosphate; UDP, uridine diphosphate).
not affected by environmental factors, the bioprocesses are easily
controlled and manipulated, and they guaranty fast and repro-
ducible production.
Some EPS containing rare sugars have been extensively studied
(Table 1), not only because of their composition, but also because
of their physical and bioactive properties. These include polymers
containing fucose, such as colanic acid (Ratto et al., 2006), fucogel
(Paul et al., 1996), clavan (Vanhooren and Vandamme, 2000), or
FucoPol (Freitas et al., 2011b), or rhamnose, such as rhamsan (Xu
et al., 2014), gellan (Zhang et al., 2015), or welan gum (Wang et al.,
2014; Figure 1).
Extensivework has been performed to discover new strains able
to produce such rare sugar-rich EPS and to improve their produc-
tion and purification processes. Many of those polymers are being
studied for new applications in pharmaceuticals cosmetics, food
products, among others. Rare sugar-rich EPS can also be used as
sources of rare sugarmonosaccharides. Such EPS can be subjected
to hydrolysis (either enzymatic or chemical) and the resulting
monomers can be separated by chromatographicmethods to yield
pure monosaccharides. The rare sugars thus obtained can then be
used as precursors for the synthesis of high-value molecules for
use in high-value applications. The exploitation of EPS as sources
of rare sugars still remains a rather unexplored and unexploited
aspect. The economic viability of such strategy depends on the
EPS content on a given rare sugar but the high demand for these
molecules will be a strong driving force.
EPS Containing Rare Sugars and Their
Producers
Even though not all rare sugars can be found inmicrobial polysac-
charides, some EPS, secreted by bacteria in specific limited con-
ditions, contain rare sugars, offering an opportunity to produce
them in sustainable and controlled conditions. These include
polymers containing fucose, such as colanic acid, fucogel, and cla-
van, or rhamnose, such as rhamsan, gellan, diutan, or welan gum,
very often in combination with uronic acids such as glucuronic or
galacturonic acids (Kumar and Mody, 2009).
Similarly to most bacterial EPS, rare sugar enriched EPS syn-
thesis occurs intracellularly (Freitas et al., 2011a,b). Energy-rich
monosaccharides, mainly nucleoside diphosphate sugars (NDP-
sugars), are synthesized from phosphorylated sugars formed from
primarymetabolites (Figure 1). Polymerization commonly occurs
at the cytoplasmic face of the innermembrane or at the periplasm,
and the polysaccharides are exported to the extracellular.
The presence of rare sugars on bacterial EPS is not well under-
stood yet, but they may provide the cells with an extra biolog-
ical protection in addition to the physical barrier provided by
the EPS.
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Rhamnose Containing EPS
Most rhamnose containing EPS belong to the family of sphin-
gans are secreted by strains of the Sphingomonas genus (Fialho
et al., 2008). Sphingans, as rhamsan, gellan, diutan, or welan gum
present a common linear tetrasaccharide repeating unitGlc-GlcA-
Glc-Rha or Man (Pollock, 1993). The presence of rhamnose or
mannose at the end the repeating unit is responsible for the main
structural variations between sphingans. For instance, diutan has
exactly the same backbone as gellan (Glu-GlcA-Glu-Rha) but is
substitutedwith Rha-Rha side chain.Klebsiella genus also presents
EPS producers. For instance, Klebsiella I-714 produces an EPS
with a high rhamnose content, composed of hexasaccharide units
of -rhamnose, -galactose, and-glucuronic acid in amolar ratio
of 3:2:1 (Serrat et al., 1995).
Fucose Containing EPS
Clavan, composed of tetrasaccharide repeating units of -glucose,
-galactose, -fucose, and pyruvic acid in the molar ratio of
1:1:2:1, is one of the richest polymers in fucose. It is produced by
Clavibacter strains, in particularC.michiganensis (Vanhooren and
Vandamme, 2000). In comparison, Fucogel, commercialized by
Solabia (France) is a linear anionic polymer produced by K. pneu-
moniae, constituted of trisaccharide repeating units of galactur-
onic acid, -fucose, and -galactose (Vanhooren and Vandamme,
2000). Amarine bacterium Enterobacter cloacaewas also reported
to produce a polymer composed fucose, galactose, glucose, and
glucuronic acid in a molar ratio of 2:1:1:1 (Iyer et al., 2005). The
strain Enterobacter A47 synthesizes FucoPol, a fucose-containing
polysaccharide with nearly equimolar amounts of fucose, glucose,
and galactose, andminor content of glucuronic acid (10–15mol%;
Freitas et al., 2011b).
Other Bacterial EPS
Even rarer sugars that rhamnose and fucosemight be encountered
in bacterial EPS. For instance, strains of the rumen bacterium
Butyrivibrio fibrisolvens produce significant amounts of EPS con-
taining -altrose and -iduronic acid (Ferreira et al., 1997). Due to
its scarcity, reports on altrose production and applications remain
still limited today. Pseudomonas viscogena produces a polysac-
charide containing another scarce sugar, allose, the C2 epimer
of altrose, but only in small proportion (around 2.5% of sugar
content; Takemoto and Igarashi, 1984). A much more studied
rare sugar containing EPS is hyaluronic acid (HA), because of
its proven properties (Collins and Birkinshaw, 2013). HA is a
linear polymer composed ofN-acetylglucosamine and glucuronic
acid, as disaccharidic repeating units produced by Streptococcus
zooepidemicus (Liu et al., 2011)
Bioproduction
Cultivation Conditions
Bacterial EPS are industrially produced in single strain systems
(Kumar and Mody, 2009). As for other bacterial EPS production
bioprocesses, the production of EPS rich in rare sugars rely on
the use of carbohydrates as carbon sources because they allow
for high productivities and yields (Table 1; Kumar et al., 2007).
Sucrose and glucose are themost commonly used substrates, while
xylose, galactose and lactose are less frequently used becausemany
bacteria are unable to use them or they result in reduced polymer
productivities (Singh et al., 2008; Zhang and Chen, 2010). Since
the substrate cost accounts for up to 40% of the total production
costs of microbial polymers (Kumar and Mody, 2009), there is an
intensive search for alternative raw materials to reduce the overall
production costs. For that reason, several inexpensive agricultural
and industrial wastes and by-products have been proposed as sub-
strates for microbial cultivation, including lignocellulosic materi-
als, cheese whey, molasses, and glycerol-rich product (Table 1).
On the other hand, the use of some agricultural and industrial
wastes/by-products is held up by the difficulty in guarantying their
supply in terms of both quantity and quality, and theymay require
costly pretreatments prior to use. Moreover, non-reacted compo-
nents may accumulate in the broth and eventually be carried-over
to the final product. Hence, for applications wherein high-purity
and high quality products are needed, the use of wastes or by-
products may not be an option or, otherwise, higher investment
must be put in downstream procedures (Freitas et al., 2011a).
Media composition and cultivation conditions highly influence
the amount of polysaccharide synthesized, as well as the final
product’s composition, molecular structure, average molecular
weight, and, consequently, their functional properties (Nicolaus
et al., 2010; Poli et al., 2011). Hence, it is possible to manipulate
polysaccharides’ characteristics by altering the growth conditions
of the producing strains, thus obtaining biopolymers with tailored
properties to fit a given application. Enrichment of the polysaccha-
rides in rare sugar monomers is of particular interest since it may
enhance their bioactive properties, thus increasing their market
value. However, the impact of media and cultivation conditions
on EPS composition is strain-dependent and only a few bacteria
can be manipulated to alter the composition of the EPS they
synthesize. In fact, for most bacteria, EPS sugar composition is a
genetically determined trait, which is not significantly altered by
the cultivation conditions (López et al., 2003; Celik et al., 2008).
An exception to this is, for example, the bacterium Enterobacter
A47 that was shown to be able to synthesize EPS with differ-
ent fucose contents by cultivation as a function of the carbon
source used and the operating conditions (Torres et al., 2012;
Freitas et al., 2014). High fucose content EPS (36–38 mol%) were
synthesized by Enterobacter A47 using glycerol or xylose as sole
carbon sources, while glucose, methanol or citrate led to lower
contents (22–29mol%; Freitas et al., 2014). On the other hand, the
composition of the EPS produced by Enterobacter A47 could also
be manipulated by cultivation at different pH and/or temperature
ranges: maximum fucose content (>30 mol%) was obtained for
cultivation at 25–35°C and pH = 6.0–8.0 (Torres et al., 2012).
Downstream Processing
The recovery of bacterial EPS from the culture broth commonly
involves cell removal, usually by centrifugation or filtration, poly-
mer precipitation from the cell-free supernatant by the addition
of a precipitating agent consisting of a water-miscible solvent
in which the polymer is insoluble (e.g., methanol, ethanol, iso-
propanol, acetone) and drying of the precipitated polymer (e.g.,
by freeze drying, drum drying; Freitas et al., 2011a, 2013). For
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some applications that require high purity grade products, the
polymer is subjected to one or several additional methods, such
as re-precipitation of the polymer from diluted aqueous solution,
deproteinization by chemical or enzymatic methods, and mem-
brane processes, such as dialysis, ultrafiltration and diafiltration
(Kumar et al., 2007; Wang et al., 2007; Ayala-Hernández et al.,
2008; Bahl et al., 2010; Freitas et al., 2011a). The most appropri-
ate downstream procedure is selected to guaranty the required
products’ purity. Additionally, the impact of the purification pro-
cedures on the polysaccharides’ properties must also be taken in
consideration.
Industrial and Biomedical Applications
Most polysaccharides’ applications are related to their behavior
in aqueous media. Their physical and chemical characteristics,
such as water binding capacity, high average molecular weight,
polyelectrolyte behavior (in some cases), molecular structure, and
the possibility of being chemically modified, enables this type
of molecules to present diverse functional properties (e.g., thick-
ening, film forming, gelling, emulsion stabilizing, flocculating,
and nano/microstructures production abilities; Dumitriu, 2004).
Furthermore, in the case fucose and rhamnose-rich bacterial
polysaccharides, they also present interesting biological activities
that render these molecules potential to be used in a wide range of
applications, particularly in added value products like cosmetics,
pharmaceuticals, medical devices, and functional food products
(Péterszegi et al., 2003a; Ravelojaona et al., 2009). As examples,
rhamnose is commonly used as precursor for the production of
aroma and flavors and, together with fucose, has attracted more
attraction as fucose and rhamnose-rich oligo- andpolysaccharides
(FROP and RROP, respectively) have been found to counteract
several of the mechanisms involved in skin aging (Robert et al.,
2009).
Gellan gum is a linear anionic EPS, and its native form contains
two acyl substituents, -glyceryl and acetyl, being known as high
acyl gellan (HA-gellan). The substituents may be removed by
alkaline hydrolysis to give deacetylated gellan, also called low acyl
gellan (LA-gellan). HA-gellan usually produces elastic, soft, non-
brittle, and opaque gels while LA-gellan enables the formation
of non-elastic, hard, brittle, and transparent gels (Sworm, 2009).
Therefore, a wide range of structures, with varied rheological
properties and appealing textures may be designed by controlling
the acyl content. Gellan produced by cultivation of a pure cul-
ture of Sphingomonas elodea using a sugar as carbon source, and
commercialized by CPKelco (with the trade name KELCOGEL®),
has been used in the food industry as additive that functions, not
only as gelling, but also as texturizing, stabilizing, suspending,
film-forming, and structuring agent. Types of food products that
contain gellan gum include bakery fillings, dairy products, low-fat
spreads, dessert gels, jams and jellies, sauces, and structured foods
(Freitas et al., 2013; Prajapati et al., 2013). It has also been used
to develop edible coatings for the improvement of fruits shelf life
(Rojas-Graü et al., 2007; Tapia et al., 2008).
The applications of gellan gum in pharmaceutical technology
and medicine were recently reviewed by Osmałek et al. (2014). In
pharmaceuticals, it has been studied as carrier material in drug
delivery, in the form of tablets, capsules, beads, and hydrogels.
Formulations based on gellan gum for oral, ophthalmic, and nasal
applications have been developed. Inmedicine field, the use of gel-
lan has been investigated for tissue engineering (e.g., for cartilage
reconstruction and guided bone regeneration) andwound healing
(e.g., in wound dressings to inhibit postsurgical adhesion and
scar formation). Gellan sulfate derivatives are promisingmaterials
for rheumatoid arthritis treatment, as they have a tendency for
selective binding of fibronectinmolecules (Miyamoto et al., 2001),
and for the development of cell-hybrid materials for artificial
veins design due to the anticoagulant activity of such derivatives
(Miyamoto et al., 2002).
Regarding welan gum, the main applications studied so far are
in the field of cement production. The use of low viscosity welan
gum in cement compositions reduces fluid loss of those composi-
tions, increases the suspension properties of cement suspensions,
being effective at low concentrations (Kaur et al., 2014). The
rheological properties of welan gum in aqueous media were com-
pared to that of xanthan gum, well known for its good thickening
capacity. For the same biopolymer concentration, welan solu-
tions presented higher apparent viscosity and higher viscoelastic
moduli (loss and storage moduli). In addition, the welan gum
solution is able to maintain high viscosity at high temperature
while the molecular aggregation of xanthan gum is more sensitive
to temperature variations (Xu et al., 2013). As such, it is envisaged
the application of welan gum in the same areas as xanthan gum,
such as in food products (e.g., jellies, beverages, dairy products,
and salad dressings); as well as in oil drilling fluids. As welan
gum is a rhamnose containing polysaccharide, attention should
be driven to the study of its biological activity and applications in
the cosmetic, pharmaceutical, and medicine fields.
Native rhamsan gum is non-gel forming polysaccharide, but
originates thermostable highly viscous solutions even at temper-
atures above 100°C. It possesses good stability under shearing,
great compatibility with high salt concentrations and excellent
suspension properties, even superior to that of xanthan gum.
Furthermore, gelationwas observed in deacetylated rhamsan gum
solution at concentrations of 0.3%wt at low temperature (Tako
et al., 2003). This polymer finds applications in the same fields
of the other polysaccharides of the gellan family, namely in the
oil field, concrete, food products, cosmetics, pharmaceuticals, and
medicine (e.g., plastic surgery), referred by Xu et al. (2014).
Fucose is another rare sugar that is today used in the com-
position of anticarcinogenic and anti-inflammatory drugs, in the
preparation of creams for the acceleration of wound healing and
as hydrating and anti-aging additives (Péterszegi et al., 2003a,b;
Cescutti et al., 2005). Fucogel, a fucose containing EPS, has been
used extensively in skin care cosmetic formulations (Bauer et al.,
2012; Tecco and Sanders, 2012). This fact is mainly due to its
moisturizing properties and to the scientific evidence of the action
of fucogel and fucogel oligosaccharides as skin anti-aging agents,
namely for stimulation of fibroblast proliferation and survival
(Péterszegi et al., 2003a). Another recently reported fucose-rich
EPS, FucoPol, has demonstrated interesting functional charac-
teristics, such as thickening, emulsion stabilizing, film forming,
and flocculating capacities (Cruz et al., 2011; Freitas et al., 2011b;
Ferreira et al., 2014). These properties envisage its application in
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several areas, namely in emulsion-based cosmetics, drug delivery
systems, biodegradable films for packaging, oil drilling fluids, and
as biodegradable bioflocculant (e.g., in wastewater treatment).
Hyaluronic acid is abundantly found inmammalian skin where
it constitutes a high fraction of the extracellular matrix of the
dermis. Its physical and biochemical properties, either in solution
or as hydrogel, are attractive for various technologies related to
body repair. As such, it is a biomaterial of increasing importance
finding applications in cosmetics, pharmaceuticals, and medicine
(Collins and Birkinshaw, 2013). Either in a stabilized form or in
combination with other polymers, it is used in cosmetic surgery
as a component of commercial dermal fillers (e.g., Dermalive®
and Hylaform®). It is reported that injection of such products
into the dermis, can reduce facial lines and wrinkles in the long
term (Brown and Jones, 2005). HA-based materials have been
applied in scaffolds for wound healing, bone and cartilage tissue
repair and regeneration, nerve and brain tissue repair, soft tissue
repair, and smooth muscle engineering (Collins and Birkinshaw,
2013). In addition, this biopolymer has been extensively explored
as drug carrier, including target specific and long-acting delivery
of protein, peptide, and nucleotide therapeutics (Oh et al., 2010).
Conclusion
Only a minority of microbial EPS are today used as commodity
products mostly because of their production and purification
costs. However, the presence of rare sugars in specific EPS may
confer them high added value, to be used in highly specialized
applications such as biomedicine, pharmaceuticals, or cosmetics.
The physical and chemical properties of the polymers determine
their potential applications as thickeners, film producers, emul-
sion stabilizers, flocculants or materials for nano/microparticles,
and scaffolds for tissue engineering among others. In addition
to that, their biological activity, potentiated by the occurrence
of rare sugars, may offer new market opportunities. EPS micro-
bial production presents the advantage of being simple, robust,
reproducible, and easily controllable by growth conditions, such
as type and concentration of carbon source, pH, or temperature.
However, despite the fact it is possible to produce a polymer with
constant characteristics (e.g., composition, purity, and homo-
geneity), a better understanding of EPS synthesis, in particular
EPS with high rare sugars content, is still needed to maximize
production and obtain an economical viable process.
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